Display options
Cite
Zhou F, Furuhashi K, Son MJ, et al. Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology. 2016;69(3):493-502doi: 10.1007/s10616-016-9965-2.
Zhou, F., Furuhashi, K., Son, M. J., Toyozaki, M., Yoshizawa, F., Miura, Y., & Yagasaki, K. (2017). Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology, 69(3), 493-502. https://doi.org/10.1007/s10616-016-9965-2
Zhou, Fang, et al. "Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice." Cytotechnology vol. 69,3 (2017): 493-502. doi: https://doi.org/10.1007/s10616-016-9965-2
Zhou F, Furuhashi K, Son MJ, Toyozaki M, Yoshizawa F, Miura Y, Yagasaki K. Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice. Cytotechnology. 2017 Jun;69(3):493-502. doi: 10.1007/s10616-016-9965-2. Epub 2016 Mar 21. PMID: 27000262; PMCID: PMC5461240.
Copy Download .nbib Format: NLM
Share it on

Cytotechnology. 2017 Jun;69(3):493-502. doi: 10.1007/s10616-016-9965-2. Epub 2016 Mar 21.

Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice.

Cytotechnology

Fang Zhou, Keisuke Furuhashi, Myoung Jin Son, Miku Toyozaki, Fumiaki Yoshizawa, Yutaka Miura, Kazumi Yagasaki

Affiliations

  1. Department of Applied Biological Chemistry, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan.
  2. Center for Bioscience Research and Education, Utsunomiya University, Utsunomiya, Tochigi, 321-8505, Japan.
  3. Department of Applied Biological Chemistry, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan. [email protected].
  4. Center for Bioscience Research and Education, Utsunomiya University, Utsunomiya, Tochigi, 321-8505, Japan. [email protected].

PMID: 27000262 PMCID: PMC5461240 DOI: 10.1007/s10616-016-9965-2

Abstract

Enterolactone (ENL) is formed by the conversion of dietary precursors like strawberry lignans via the gut microbiota. Urinary concentrations of lignan metabolites are reported to be significantly associated with a lower risk of Type 2 diabetes (T2D). In the present study, antidiabetic effect of ENL and its modes of action were studied in vitro and in vivo employing a rat skeletal muscle-derived cell line, L6 myocytes in culture, and T2D model db/db mice. ENL dose-dependently increased glucose uptake in L6 myotubes under insulin absent condition. This increase by ENL was canceled by compound C, an inhibitor of 5'-adenosine monophosphate-activated protein kinase (APMK). Activation (=phosphorylation) of AMPK and translocation of glucose transporter 4 (GLUT4) to plasma membrane in L6 myotubes were demonstrated by Western blotting analyses. Promotion by ENL of GLUT4 translocation to plasma membrane was also visually demonstrated by immunocytochemistry in L6 myoblasts that were transfected with glut4 cDNA-coding vector. T2D model db/db mice were fed the basal 20 % casein diet (20C) or 20C supplemented with ENL (0.001 or 0.01 %) for 6 weeks. Fasting blood glucose (FBG) levels were measured every week and intraperitoneal glucose tolerance test (IPGTT) was conducted. ENL at a higher dose (0.01 % in 20C) suppressed the increases in FBG levels. ENL was also demonstrated to improve the index of insulin resistance (HOMA-IR) and glucose intolerance by IPGTT in db/db mice. From these results, ENL is suggested to be an antidiabetic chemical entity converted from dietary lignans by gut microbiota.

Keywords: AMPK; Enterolactone; GLUT4; L6 myocytes; db/db mice

References

  1. Nutr Cancer. 2007;58(1):49-59 - PubMed
  2. Nutrition. 2012 Jan;28(1):9-19 - PubMed
  3. Cytotechnology. 2015 Aug;67(4):641-52 - PubMed
  4. Br J Nutr. 2000 Apr;83(4):381-7 - PubMed
  5. Cell. 2012 Feb 3;148(3):421-33 - PubMed
  6. Biochem Pharmacol. 2010 Jun 1;79(11):1674-83 - PubMed
  7. Diabetes Care. 2014;37(5):1287-95 - PubMed
  8. Cytotechnology. 2015 Aug;67(4):699-710 - PubMed
  9. J Nutr Biochem. 2012 May;23(5):501-9 - PubMed
  10. Food Funct. 2014 Mar;5(3):491-501 - PubMed
  11. FASEB J. 2006 Apr;20(6):705-7 - PubMed
  12. Cytotechnology. 2003 Nov;43(1-3):97-103 - PubMed
  13. Biosci Biotechnol Biochem. 2007 Sep;71(9):2343-6 - PubMed
  14. J Clin Invest. 2001 Oct;108(8):1167-74 - PubMed
  15. Lancet. 1981 Jul 4;2(8236):4-7 - PubMed
  16. Med Sci Sports Exerc. 2004 Jul;36(7):1212-7 - PubMed
  17. J Nutr Biochem. 2014 Feb;25(2):136-43 - PubMed
  18. Biochem Biophys Res Commun. 2012 Jun 8;422(3):469-75 - PubMed
  19. Phytomedicine. 2009 May;16(5):437-43 - PubMed
  20. J Clin Biochem Nutr. 2011 May;48(3):237-44 - PubMed
  21. J Agric Food Chem. 2014 May 7;62(18):3867-76 - PubMed
  22. Mol Nutr Food Res. 2014 Feb;58(2):267-77 - PubMed
  23. J Nutr. 2003 May;133(5):1368-75 - PubMed
  24. Nutr Cancer. 2000;36(1):27-32 - PubMed
  25. Eur J Nutr. 2013 Sep;52(6):1607-19 - PubMed
  26. Mol Nutr Food Res. 2007 Jul;51(7):857-66 - PubMed
  27. Biofactors. 2014 Jul-Aug;40(4):436-47 - PubMed
  28. Lancet. 1999 Dec 18-25;354(9196):2112-5 - PubMed

Publication Types